Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 6,517-6,528 of 9,138
Other study type icon
Active Not RecruitingNCT05396625

Reintegration of Children From Institutions in Azerbaijan

This study is active but not recruiting. It focuses on mental health and currently lists study information in Azerbaijan.

In Baku
Mental healthOtherFrom 7 Years to 12 Years
Countries
Azerbaijan
Sponsor
University of Chicago
Condition
Mental health
Other study type icon
CompletedNCT00044616

Relapse Prevention for Bipolar Type-II Disorder

This study is completed. It focuses on bipolarity and currently lists study information in the United States.

In Philadelphia
Bipolarity, DepressionOtherFrom 18 Years to 100 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Bipolarity, Depression
Other study type icon
WithdrawnNCT04553263

Relapse Prevention in Stimulant Use Disorder

This study has public registry information. It focuses on ADHD and currently lists study information in the United States.

In Los Angeles
ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
ADHD
Other study type icon
CompletedNCT01291511

Relapse Prevention Study in people with Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in India, Ukraine, and the United States.

Multiple locations, including Anaheim
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States, India, Ukraine
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Other study type icon
Enrolling By InvitationNCT04214561

Relationship Between Selected Parameters and Bruxism

This study is enrolling by invitation. It focuses on anxiety and currently lists participation information in Poland.

In Wroclaw
AnxietyOtherFrom 18 Years to 70 Years
Countries
Poland
Sponsor
Wroclaw Medical University
Condition
Anxiety
Drug study icon
CompletedNCT04922593

Relative Bioavailability of LY03010 Compared to Listed Drug

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including Garden Grove
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Mental Health | Clinical Trials | HopeStage Research